Neisseria meningitidis

Snapshot

  • An 18-year-old man presents to the emergency department for an intractable headache and generalized malaise. His symptoms began 3 days ago and have progressively worsened. Physical examination is significant for nuchal rigidity, diffuse petechia, and an inability to extend at the knee while the hips are flexed at 90°. A lumbar puncture is performed and cerebral spinal fluid studies demonstrate an elevated opening pressure, elevated protein, decreased glucose, and a leukocytosis. Gram stain of the cerebral spinal fluid demonstrates gram-negative diplococci.

Introduction

  • Classification
    • a gram-negative diplococcus
  • Epidemiology
    • risk factors 
      • college students
      • military
      • infants and the elderly
      • no meningococcus vaccine
  • Transmission
    • respiratory and oral secretions
  • Microbiology
    • properties
      • metabolizes glucose
      • produces IgA proteases
      • contains lipooligosaccharides (has strong endotoxin activity)
      • aerobic or facultatively anaerobic
      • maltose fermenter 
    • reservoir
      • nasopharynx
        • penetrates mucosal epithelium and enters circulation
          • pharynx → hematogenous spread (blood) → choroid plexus → meninges 
    • molecular biology
      • virulence factors
        • polysaccharide capsule 
          • an important virulence factor
            • provides resistance against phagocytosis
        • IgA protease
          • allows oropharynx colonization
        • endotoxin (lipooligosaccharide) 
          • analogous to LPS from other gram-negative bacteria
          • causes hemorrhage and sepsis
          • responsible for petechial rash
            • small red dots of hemorrhage
        • pili
          • enables attachment to the nasopharynx 
          • antigenic variation avoids the immune system attack
  • Pathogenesis
    • begins as asymptomatic colonization in the nasopharynx in healthy patients
      • in rare cases, the bacteria invade through the mucosa, resulting in bacteremia, which can allow seeding of the microbe to the meninges
      • an inflammatory response against the microbe (due to its endotoxin) ensues, leading to tissue injury
        • procoagulant pathways can also be activated, causing intravascular thrombosis (e.g., purpura and petechiae)
    • Patients deficient in components of the alternative and terminal complement (C5b-C9 – membrane attack complex) pathways have increased susceptibility to recurrent Neisseria bacteremia
  • Prevention
    • meningococcal vaccine
      • indication
        • all patients 11-18 years of age
        • ≤ 10 years of age and ≥ 19 years of age who are high risk for invasive meningococcal disease
  • Associated conditions
    • meningitis
    • meningococcemia
    • purpural fulminans
    • Waterhouse-Friderichsen syndrome  
      • adrenal infarction leading to adrenal insufficiency 
  • Prognosis
  • poor prognosis include shock, young and old age, coma, purpura fulminans, and disseminated intravascular coagulation

Presentation

  • Symptoms
    • headache
    • fever
    • neck stiffness
    • nausea and vomiting
    • myalgias
  • Physical
    • petechial rash 
    • nuchal rigidity
    • Brudzinki sign
      • spontaneous flexion of the hips during passive neck flexion
    • Kernig sign
  • inability to extend the knees while the hips are flexed at 90°

Studies

  • Culture
    • perform a Gram stain of the cerebral spinal fluid or blood
  • gold standard for the diagnosis

Differential

  • Meningitis caused by other organisms
    • Streptococcus pneumoniae
    • Listeria monocytogenes
    • differentiating factors
  • different organisms are isolated with microbiologic testing

Treatment

  • Medical
    • empiric antibiotic therapy
      • indication
        • preferably given after cerebral spinal fluid cultures and blood cultures are obtained
          • given antibiotics first will impair diagnostic testing
      • regimen
        • third-generation cephalosporin
          • e.g., ceftriaxone or cefotaxime 
    • antimicrobial chemoprophylaxis
      • indication
        • ideally given within 24 hours
          • household members
          • roommates or intimate contacts
          • direct exposure to oral or respiratory secretions (e.g., kissing and endotracheal intubation)
          • sitting next to the infectious person for ≥ 8 hours
          • patients who work in a childcare center
      • medication
        • rifampin
        • ciprofloxacin
  • ceftriaxone

Complications

  • Sepsis
  • Hypovolemic shock
  • Cerebral edema and hydrocephalus
  • Cognitive impairment